skip to content

Investors

Roche has hosted a virtual event on Monday, 23 June 2025


A gloved hand in a lab coat holds a small, clear vial against a blurred background of lab equipment, conveying a scientific and clinical setting.

Thursday, 24 July 2025 at 14:00 CEST


A blue-gloved hand delicately holds a small pink container with a QR code. Nearby are green, blue, and yellow containers on a white surface, indicating a scientific setting.

patients were treated with Roche medicines in 2024

Roche Diagnostics test were delivered to customers worldwide in 2024

Core investments in research and development in 2024: CHF 13.2 billion

Our two divisions are focusing jointly on three disease areas that will account for almost 50% of the global disease burden by 2035: cancer, cardiovascular-metabolic diseases and neurological diseases.

Portrait of Thomas Schinecker

Dr Thomas Schinecker

CEO Roche Group

Upcoming Investor events

Roche Half Year Results 2025 (virtual event)Investors

July 24, 2025 at 14:00 CEST | Basel, Switzerland

UBS Precision Medicine Frontiers SummitInvestors

August 14, 2025 at 10:00 PDT | Dana Point, US

22nd Annual Goldman Sachs European Medtech and Healthcare Services ConferenceInvestors

September 04, 2025 at 08:00 BST | London, UK

Morgan Stanley 23rd Annual Global Healthcare ConferenceInvestors

September 09, 2025 at 08:30 EST | New York, US

Nephron Napa Summit 2025Investors

September 17, 2025 at 10:00 PDT | Yountville, US

Roche's Pharma Day 2025Investors

September 22, 2025 at 09:00 BST | London, UK

Investor relations team contacts

Do you need to get in touch with us? Reach out to our investor relations team with your enquiries.